Live Analyst Rating Changes 5178 upgrades, downgrades & price-target moves · freshest Wall Street data, updated daily View live feed →
Analyst Tracker/Douglas Loe
LF
Douglas Loe
Leede Financial
Wall Street Analyst
★★★☆☆
#1682
on 13Foresight · ranked by our own returns
25%
Success Rate
+39.3%
Average Return
1 of 4 calls profitable · +19.1% vs benchmark
📈 Across the calls we could measure, roughly 25% of Douglas Loe's ratings turned a profit when each position was held for 1 year — averaging +39.3% per rating. These figures are computed by 13Foresight from historical prices, not supplied by the analyst.

Rating Distribution

8 Buy 0 Hold 0 Sell
Douglas's Stock Coverage 21 ratings · 2026-07-06
Company Date Position Consensus ⓘ Price Target ⓘ 1-Yr Return
TSE:MSCL
Satellos Bioscience
 Mar 11, 2026 BUY Strong Buy
+186.3% avg upside
6 analysts
$22.70
108.20% Upside
 ·
TSE:PINK
Perimeter Medical Imaging AI
 Mar 08, 2026 BUY Strong Buy
+909.2% avg upside
4 analysts
$3.00
990.83% Upside
 ·
TSE:NSCI
Nanalysis Scientific
 Nov 27, 2025 BUY Strong Buy
+300.0% avg upside
1 analyst
$0.50
299.96% Upside
 ·
ONCY
Oncolytics Biotech
 Nov 25, 2025 BUY Strong Buy
+703.6% avg upside
12 analysts
$4.00
344.89% Upside
 -17.5%
TSE:CRDL
Cardiol Therapeutics
 Aug 08, 2025 BUY Strong Buy
+626.7% avg upside
6 analysts
$15.61
920.25% Upside
 ·
PMN
ProMIS Neurosciences
 Jul 22, 2025 BUY Strong Buy
+391.0% avg upside
7 analysts
 — -47.3%
TSE:DR
Medical Facilities
 Aug 07, 2024 BUY Buy
-5.5% avg upside
2 analysts
$15.50
15.14% Downside
 ·
TSE:SVA
Sernova
 Jun 30, 2023 BUY Strong Buy
+2793.1% avg upside
3 analysts
$4.68
3502.15% Upside
 ·
TSE:EXE
Extendicare
 May 08, 2023 HOLD Strong Buy
-24.9% avg upside
8 analysts
$7.00
81.32% Downside
 ·
IMVIF
IMV
 Apr 12, 2022 BUY Buy
+2413397149.9% avg upside
7 analysts
$42.28
4228181899.91% Upside
 ·
TSE:APLI
Appili Therapeutics Inc Class A
 Feb 28, 2022 HOLD Buy
+8306.4% avg upside
3 analysts
$0.25
1566.65% Upside
 ·
GRCE
Grace Therapeutics
 Aug 31, 2020 SELL Strong Buy
+154.1% avg upside
9 analysts
$0.11
95.59% Downside
 -39.1%
NEPTF
Neptune Wellness Solutions
 Aug 27, 2020 BUY Strong Buy
+400486303.1% avg upside
7 analysts
$3.52
352348400.04% Upside
 ·
TSE:KBL
K-Bro Linen
 Aug 14, 2020 HOLD Strong Buy
-2.7% avg upside
4 analysts
$29.00
35.86% Downside
 ·
TSE:CRRX
CareRx
 Aug 14, 2020 BUY Strong Buy
+55.2% avg upside
5 analysts
$7.00
101.10% Upside
 ·
TSE:CPH
Cipher Pharmaceuticals
 Aug 13, 2020 BUY Strong Buy
-48.6% avg upside
4 analysts
$3.00
82.59% Downside
 ·
TSE:PRN
Profound Medical
 Aug 07, 2020 BUY Strong Buy
+101.2% avg upside
11 analysts
$37.50
301.11% Upside
 ·
CLAZF
Claritas Pharmaceuticals
 Jun 16, 2020 BUY Strong Buy
1 analyst
 — ·
ABUS
Arbutus Biopharma
 Oct 07, 2019 HOLD Strong Buy
+81.4% avg upside
15 analysts
$1.00
79.49% Downside
 +260.9%
REPCF
RepliCel Life Sciences
 Feb 28, 2017 BUY Strong Buy
+2149900.0% avg upside
1 analyst
$2.15
2149900.03% Upside
 ·
IMRSQ
IMRIS
 Mar 19, 2013 BUY Strong Buy
+3452281.0% avg upside
3 analysts
 — ·
🔒 16 more ratings — with price targets, crowd consensus and our measured returns.
Sign in free to unlock See Pro plans
Free account unlocks every analyst's full coverage table.
Douglas Loe — Frequently Asked Questions
How accurate are Douglas Loe's stock ratings?
Based on the calls 13Foresight could measure, about 25% of Douglas's ratings were profitable over a one-year hold, with an average return of +39.3% per rating, or +19.1% versus the S&P 500. We score every analyst the same way, from historical prices.
How is Douglas ranked on 13Foresight?
Douglas Loe is currently ranked #1682 with a 3-star rating. Our rank blends hit rate, average return versus the market, and how many calls we have to judge — so a long, consistent record outweighs a few lucky picks. It is our own calculation, updated daily.
Which stocks does Douglas cover?
Douglas most recently has ratings on TSE:MSCL, TSE:PINK, TSE:NSCI, ONCY, TSE:CRDL, PMN, TSE:DR, TSE:SVA, TSE:EXE, IMVIF, TSE:APLI, GRCE and 9 more. See the full coverage table above for positions, price targets and our measured returns.
Where can I see other analyst ratings?
Browse the full analyst leaderboard to compare Wall Street analysts ranked by their measured performance, success rate and average return.

Disclaimer: 13Foresight compiles analyst ratings and price targets from publicly available sources. Performance metrics, rankings and star ratings shown here are calculated independently by 13Foresight from historical market prices and may differ from figures published elsewhere. This information may be incomplete, delayed or inaccurate, is provided for research and informational purposes only, and is not investment advice. The underlying ratings and opinions are those of the respective analysts and their firms; 13Foresight accepts no liability for any decisions made based on this data.